Q3 Earnings Estimate for Ardelyx Issued By Leerink Partnrs
Ardelyx, Inc. (NASDAQ:ARDX – Free Report) – Analysts at Leerink Partnrs issued their Q3 2025 earnings per share (EPS) estimates for shares of Ardelyx in a research report issued on Thursday, February 20th. Leerink Partnrs analyst R. Ruiz anticipates that the biopharmaceutical company will post earnings per share of ($0.03) for the quarter. The consensus […]
Ardelyx, Inc. (NASDAQ:ARDX – Free Report) – Analysts at Leerink Partnrs issued their Q3 2025 earnings per share (EPS) estimates for shares of Ardelyx in a research report issued on Thursday, February 20th. Leerink Partnrs analyst R. Ruiz anticipates that the biopharmaceutical company will post earnings per share of ($0.03) for the quarter. The consensus […]
